TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024.

授予 NIMH 精神活性药物筛查计划 (PDSP) 基期。

• 批准号: 10931140
• 负责人: BRYAN ROTH
• 金额: $ 309.75万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-30 至 2024-08-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10931140
• 关键词: Award; Basic Science; Brain imaging; Clinical Research; Functional Magnetic Resonance Imaging; Imaging ligands; Mental disorders; National Institute of Mental Health; Natural Products; Positron-Emission Tomography; Psychotropic Drugs; Research; Therapeutic Agents; base; novel; screening; screening program; single photon emission computed tomography; tool

The purpose of the NIMH PDSP is to provide screening of novel synthetic compounds and natural products for potential use as research tools or probes for basic and clinical research, as therapeutic agents for mental disorders, and as positron emission tomography (PET), single photon emission computed tomography (SPECT), and functional magnetic resonance imaging (fMRI) ligands for functional brain imaging.

NIMH PDSP的目的是为以下物质提供新的合成化合物和天然产物的筛选 可能作为基础和临床研究的研究工具或探针，作为治疗精神障碍的药物，以及作为功能脑成像的正电子发射断层扫描(PET)、单光子发射计算机断层扫描(SPECT)和功能磁共振成像(FMRI)配体。